SE317376B - - Google Patents
Download PDFInfo
- Publication number
- SE317376B SE317376B SE7555/62A SE755562A SE317376B SE 317376 B SE317376 B SE 317376B SE 7555/62 A SE7555/62 A SE 7555/62A SE 755562 A SE755562 A SE 755562A SE 317376 B SE317376 B SE 317376B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR867515A FR1399M (fr) | 1961-07-10 | 1961-07-10 | Nouveau médicament notamment pour le traitement de manifestations inflammatoires et douloureuses. |
| FR876199A FR1369967A (fr) | 1961-10-17 | 1961-10-17 | Nouveaux dérivés de la quinoléine et procédé de préparation |
| FR899417A FR90802E (fr) | 1961-10-17 | 1962-06-01 | Nouveaux dérivés de la quinoléine et procédé de préparation |
| FR11769A FR92111E (fr) | 1961-10-17 | 1965-04-02 | Nouveaux dérivés de la quinoléine et procédé de préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE317376B true SE317376B (es) | 1969-11-17 |
Family
ID=27444351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7555/62A SE317376B (es) | 1961-07-10 | 1962-07-05 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US3376195A (es) |
| CH (1) | CH424780A (es) |
| GB (1) | GB964143A (es) |
| SE (1) | SE317376B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1573599A (en) * | 1978-05-24 | 1980-08-28 | Wyeth John & Brother Ltd | 4-aminoquinoline derivatives |
| US4876261A (en) * | 1987-03-27 | 1989-10-24 | Akihiro Tanaka | Substituted tetrahydroisoquinoline compounds and composition containing them |
| AU733551B2 (en) | 1996-09-25 | 2001-05-17 | Astrazeneca Ab | Qinoline derivatives inhibiting the effect of growth factors such as VEGF |
| GB9910580D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
| GB9910579D0 (en) | 1999-05-08 | 1999-07-07 | Zeneca Ltd | Chemical compounds |
| DE60121931T2 (de) * | 2000-04-07 | 2007-03-01 | Astrazeneca Ab | Chinazolinverbindungen |
| WO2002036570A1 (en) * | 2000-11-02 | 2002-05-10 | Astrazeneca Ab | 4-substituted quinolines as antitumor agents |
| GB0215823D0 (en) * | 2002-07-09 | 2002-08-14 | Astrazeneca Ab | Quinazoline derivatives |
| GB0225579D0 (en) * | 2002-11-02 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
| JP4503022B2 (ja) * | 2003-12-23 | 2010-07-14 | ファイザー・インク | 新規キノリン誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1181485A (en) * | 1914-12-04 | 1916-05-02 | Hoechst Ag | Oxyphenylquinolin-dicarboxylic acid and process of making same. |
| US1810267A (en) * | 1927-12-07 | 1931-06-16 | Winthrop Chem Co Inc | Alkyl-quinolyl-amino-phenyl carboxylic acids |
| US2474823A (en) * | 1945-11-05 | 1949-07-05 | Parke Davis & Co | Quinoline compounds and process of making same |
| US2994640A (en) * | 1957-02-22 | 1961-08-01 | Byk Gulden Lomberg Chem Fab | Anti-inflammatory therapy with purine molecular compounds |
| US2935448A (en) * | 1959-02-25 | 1960-05-03 | Royall M Calder | Phosphatide therapeutic composition and method of treatment therewith |
-
1962
- 1962-07-05 SE SE7555/62A patent/SE317376B/xx unknown
- 1962-07-06 CH CH817162A patent/CH424780A/fr unknown
- 1962-07-10 GB GB26511/62A patent/GB964143A/en not_active Expired
-
1966
- 1966-10-11 US US585763A patent/US3376195A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CH424780A (fr) | 1966-11-30 |
| US3376195A (en) | 1968-04-02 |
| GB964143A (en) | 1964-07-15 |